TAG:
test for prostate cancer
Health Insurers Want More Data On Clinical Utility of Molecular, Genetic Tests
CEO SUMMARY: Genetic tests that lack two essentials are troublesome for the nation’s health insurers. Those essentials are clinical validity and clinical utility. During a recent webinar, two executives from major health insurers stressed the need for genetic testing labs to provide acc…
CURRENT ISSUE
Volume XXIX, No. 6 – April 25, 2022
The Dark Report examines the lab staffing shortage crisis, including the causes and potential remedies. In other news, the Ramesh Balwani trial, like that of Elizabeth Holmes, is raising questions of who is responsible for lab problems — the lab director or company executives. Also, the DOJ contends in a court motion that EKRA governs lab sales and marketing commissions.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.